These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7020434)

  • 1. Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease.
    Fisman M; Mersky H; Helmes E
    Am J Psychiatry; 1981 Jul; 138(7):970-2. PubMed ID: 7020434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deanol in the treatment of tardive dyskinesia.
    Simpson GM; Voitashevsky A; Young MA; Lee JH
    Psychopharmacology (Berl); 1977 May; 52(3):257-61. PubMed ID: 406628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
    de Montigny C; Chouinard G; Annable L
    Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemiballismus-hemichorea treated with dimethylaminoethanol.
    Jameson HD; Blacker HM; Fuchs ME
    Dis Nerv Syst; 1977 Nov; 38(11):931-2. PubMed ID: 913228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-dimethylaminoethanol (Deanol) in Huntington's chorea.
    Caraceni TA; Girotti F; Celano I; Parati E; Balboni L
    J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1114-8. PubMed ID: 153384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind evaluation of deanol in tardive dyskinesia.
    Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D
    JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
    Lindeboom SF; Lakke JP
    Acta Neurol Scand; 1978 Aug; 58(2):134-8. PubMed ID: 360761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychological study of the senile brain during and after single and combined treatment with deanol and citicoline].
    Bonavita E
    Clin Ter; 1986 Jun; 117(5):387-98. PubMed ID: 3742961
    [No Abstract]   [Full Text] [Related]  

  • 10. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R
    Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D; Bralower M
    Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind controlled trial of deanol in tardive dyskinesia.
    George J; Pridmore S; Aldous D
    Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Dimethylaminoethanol ineffective in Huntington's disease.
    Reibling A; Reyes P; Jameson HD
    N Engl J Med; 1975 Oct; 293(14):724. PubMed ID: 125853
    [No Abstract]   [Full Text] [Related]  

  • 15. [Deanol in tardive dyskinesia: a double-blind study (author's transl)].
    Bockenheimer S; Lucius G
    Arch Psychiatr Nervenkr (1970); 1976 Sep; 222(1):69-75. PubMed ID: 791197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senile dementia: treatment with deanol.
    Ferris SH; Sathananthan G; Gershon S; Clark C
    J Am Geriatr Soc; 1977 Jun; 25(6):241-4. PubMed ID: 864168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood alterations during deanol therapy.
    Casey DE
    Psychopharmacology (Berl); 1979 Apr; 62(2):187-91. PubMed ID: 111283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia.
    Lonowski DJ; Sterling FE; King HA
    Psychol Rep; 1979 Oct; 45(2):415-9. PubMed ID: 538170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.